Edesa Biotech Inc. (EDSA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Edesa Biotech Inc.

NASDAQ: EDSA · Real-Time Price · USD
2.57
-0.18 (-6.55%)
At close: Oct 03, 2025, 3:59 PM
2.61
1.56%
After-hours: Oct 03, 2025, 07:15 PM EDT

Edesa Biotech Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-5.92M -5.84M -6.11M -6.17M -6.93M -7.25M -7.72M -8.37M -9.47M -13.27M -15.51M -17.55M -18.42M -17.39M -15.08M -13.34M -11.67M -8.68M -7.91M
Depreciation & Amortization
137.61K 163.24K 184.13K 186.05K 187.81K 219.4K 201.31K 183.47K 166.46K 113.06K 115.63K 118.19K 118.16K 119.77K 119.7K 118.79K 118.87K 111.16K 84K
Stock-Based Compensation
419.15K 341.77K 275.22K 194.22K 100.8K 911.43 1.11K 1.26K 1.2K 566.47K 1.2M 1.81M 2.71M 3.24M 3.08M 3.2M 2.38M 1.4M 1.31M
Other Working Capital
-1.2M -1.1M -60.77K -95.55K 582.69K 688.91K 571.81K 590.87K -4.86M -5.19M -4.99M -5.23M 1.13M 1.77M -91.6K -282.33K -1.32M -2M -504.12K
Other Non-Cash Items
12.73K 48.04K -5.58K -5.58K -5.58K -15.08K -12.45K -12.45K -12.45K -1.57M -1.56M -1.56M 5.31M 6.87M 6.87M 6.87M 721.53K 1.12M 1.51M
Deferred Income Tax
n/a n/a n/a -3.87K 357K -107.39K -76.94K -433.94K 2.84M 4.87M 4.84M 5.2M -4.8M -6.36M -6.36M -6.36M -721.97K -721.97K -1.12M
Change in Working Capital
-1.22M -388.87K 504.61K 571.38K 403.78K -258.5K 167.69K 308K -2.68M -503.8K 2.54M 2.89M 8.08M 6.42M -2.49M -4.15M -5.81M -6.45M -1.09M
Operating Cash Flow
-6.57M -5.67M -5.02M -4.91M -5.41M -6.36M -6.25M -6.64M -10.8M -12.02M -10.86M -12.28M -7.01M -7.1M -13.86M -13.66M -14.98M -13.22M -7.21M
Capital Expenditures
3.00 -0.66 -0.66 -3.66 -3.66 n/a n/a n/a 41.00 -1.32K -2.52K -5.66K -4.23K -6.39K -8.15K -6.15K -11.64K -37.61K -34.65K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -210
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 500K 500K 500K
Other Investing Acitivies
n/a 3.66 3.66 3.66 3.66 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -492.43K -489.77K 30.09K
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a 41.00 -1.32K -2.52K -5.66K -4.23K -6.39K -8.15K -6.15K -4.07K -27.38K 495.23K
Debt Repayment
-128 -22.93K -29.46K -29.46K -29.33K -29.68K n/a n/a n/a n/a n/a n/a n/a n/a n/a 15.35K 15.43K 44.28K 44.28K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
12.36K 220.92K 1.37K 1.37K -2K -22.14K -26.4K -26.4K 151.27K 218.69K 253.62K 253.62K 533.01K 185.19K -48.68K -48.68K -673.63K -310.56K -68.25K
Financial Cash Flow
17.03M 16.92M 2.36M 592.03K 1.04M 1.67M 2.22M 4.83M 4.42M 3.68M 13.31M 11.63M 11.85M 11.87M 13.41M 14.17M 17.18M 17.14M 9.04M
Net Cash Flow
10.32M 11.1M -2.7M -4.32M -4.42M -4.67M -4M -1.73M -6.35M -8.42M 2.39M -748.34K 4.76M 4.92M -424.54K 625.56K 2.41M 3.98M 2.48M
Free Cash Flow
-6.57M -5.67M -5.02M -4.91M -5.41M -6.36M -6.25M -6.64M -10.8M -12.02M -10.87M -12.28M -7.01M -7.11M -13.87M -13.67M -14.99M -13.25M -7.24M